Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives
Bridget A Graney, Joyce S Lee Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA Abstract: Patients with idiopathic pulmonary fibrosis, an incurable, progressive fibrotic interstitial lung disease, suffer an impaired quality of...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | Patient Related Outcome Measures |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-novel-antifibrotic-therapy-on-patient-outcomes-in-idiopathic-peer-reviewed-article-PROM |